Biondo Focus Fund Investor Class (BFONX)

16.80
Net Asset Value
-1.12%
1 Day
+3.83%
Year-to-Date
Overall Morningstar Rating
Large growth
Style or Category
No Load
Sales Expenses
3.59%
Expense Ratio
High
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund invests primarily in a combination of long and short positions in (1) common stock of U.S. companies of any capitalization; (2) American depositary receipts ("ADRs") representing common stock of foreign companies; (3) investment-grade fixed-income securities; (4) exchange-traded funds and (5) options on common stock, ADRs and ETFs. It may also employ leverage including bank borrowing of up to 33% of the fund's assets (defined as net assets plus borrowing for investment purposes). The fund is non-diversified.

Performance

1 month+5.99% 3 years+18.96%
3 months+1.27% 5 years--
1 year+12.45% Since inception+9.49%
Data through --

Peer Comparisonvs. Large growth

 BFONXCategory
Performance 5-yr return--+14.09%
Expense ratio3.59%1.22%
Risk 5 year sharpe ratio--1.03
Net assets$30.1M$2.7B
Average market cap$25.8B$70.2B
Average P/E25.920.9
Portfolio turnover81%81%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyBiondo Investment Advisor
Fund manager & tenureJoseph Biondo, Sr. / 4 Years
Minimal initial investment$1,000.00
Minimum IRA investment$500.00

Holdings

U.S. stock97.54%
Cash2.46%
International stock0.00%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 32.03%
Financial service 21.84%
Hardware 16.61%
Consumer goods 15.35%
Industrial materials 7.19%
Top 10 Holdings
Portfolio weighting
PCRX Pacira Pharmaceuticals Inc10.86%
-- 10.83%
ILMN Illumina Inc9.05%
CELG Celgene8.57%
GILD Gilead Sciences7.22%
CMRX Chimerix Inc5.36%
ISRG Intuitive Surgical5.27%
F Ford5.22%
AAPL Apple5.07%
MA MasterCard4.75%

To view my watchlist

Not a member yet?

Sign up now for a free account